In conditions in which you could need access to a medically-important drug for a significant or daily life-threatening condition wherever there is not any current market licensed drug readily available in copyright and for which option common therapies have unsuccessful or are unsuitable, Well being copyright's Distinctive Entry Programme (SAP) is